tiprankstipranks
Trending News
More News >
PRISM BioLab Co. LTD (JP:206A)
:206A
Japanese Market

PRISM BioLab Co. LTD (206A) Financial Statements

Compare
0 Followers

PRISM BioLab Co. LTD Financial Overview

PRISM BioLab Co. LTD's market cap is currently ¥7.61B. The company's EPS TTM is ¥-7.74; its P/E ratio is -5.04; PRISM BioLab Co. LTD is scheduled to report earnings on February 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Sep 24Sep 23Sep 22
Income Statement
Total Revenue¥ 677.33M¥ 305.62M¥ 112.93M¥ 554.40M
Gross Profit¥ 269.76M¥ 160.54M¥ 80.31M¥ 535.14M
Operating Income¥ -774.45M¥ -782.39M¥ -496.87M¥ 66.68M
EBITDA¥ -831.28M¥ -1.05B¥ -488.13M¥ 67.89M
Net Income¥ -833.70M¥ -1.05B¥ -526.91M¥ 72.96M
Balance Sheet
Cash & Short-Term Investments¥ 2.92B¥ 4.39B¥ 1.13B¥ 1.69B
Total Assets¥ 3.09B¥ 4.53B¥ 1.21B¥ 1.74B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -2.92B¥ -4.39B¥ -1.13B¥ -1.69B
Total Liabilities¥ 376.86M¥ 1.03B¥ 63.41M¥ 65.23M
Stockholders' Equity¥ 2.71B¥ 3.50B¥ 1.15B¥ 1.67B
Cash Flow
Free Cash Flow¥ -1.53B¥ -61.55M¥ -548.40M¥ 97.25M
Operating Cash Flow¥ -1.47B¥ 150.14M¥ -513.81M¥ 102.96M
Investing Cash Flow¥ -69.01M¥ -244.19M¥ -40.38M¥ -7.87M
Financing Cash Flow¥ 33.59M¥ 3.37B¥ 0.00¥ 110.87M
Currency in JPY

PRISM BioLab Co. LTD Earnings and Revenue History

PRISM BioLab Co. LTD Debt to Assets

PRISM BioLab Co. LTD Cash Flow

PRISM BioLab Co. LTD Forecast EPS vs Actual EPS